This is a Phase 3b, open-label study in patients that present to the ED for an opioid OD and
receive treatment with an opioid antagonist. The study is designed to determine effect of
SUBLOCADE on repeat overdose and death compared to historical control data.
The study will assess subjects that receive acute administration of SUBOXONE sublingual film
in the Emergency Department (ED) followed by SUBLOCADE administration in the ED and referral
to an affiliated outpatient treatment clinic, compared to historical control data from
electronic health records.